Sofinnova

Press

 

Event

Feb 04, 2019

Jim Healy to join Bio CEO & Investor Panel "Are Record Levels of IPOs Still Disrupting M&A Deals?"

Jim Healy to join Bio CEO & Investor Panel "Are Record Levels of IPOs Still Disrupting M&A Deals?"

Portfolio News

Jan 31, 2019

Kiniksa Pharmaceuticals Announces Pricing of Public Offering

Kiniksa Pharmaceuticals Announces Pricing of Public Offering

Sofinnova News

Jan 25, 2019

A Top VC At a $2B Fund That Invests in Risky Biotechs Reveals How He Finds His Best Investments

A Top VC At a $2B Fund That Invests in Risky Biotechs Reveals How He Finds His Best Investments

Event

Dec 13, 2018

Mike Powell joins AACR Panel "Entrepreneurship in Translational Research"

Mike Powell joins AACR Panel "Entrepreneurship in Translational Research"

Event

Dec 12, 2018

Jim Healy to join Biotech Showcase Panel "Rare and Orphan Diseases"

Jim Healy to join Biotech Showcase Panel "Rare and Orphan Diseases"

Event

Dec 12, 2018

Charlotte Shropshire to Moderate SuperReturn US West Session "Changing Lanes""

Charlotte Shropshire to Moderate SuperReturn US West Session "Changing Lanes""

Event

Dec 12, 2018

Jim Healy to join East | West CEO Panel "VC Perspectives: Currant Financing Trends in Biotech"

Jim Healy to join East | West CEO Panel "VC Perspectives: Currant Financing Trends in Biotech"

Portfolio News

Dec 06, 2018

XyloCor Therapeutics Raises $17 Million in Series A

XyloCor Therapeutics Raises $17 Million in Series A

Portfolio News

Nov 27, 2018

BioClin Therapeutics Announces Name Change to Rainier Therapeutics

BioClin Therapeutics Announces Name Change to Rainier Therapeutics

Portfolio News

Nov 13, 2018

NextCure Completes a $93M Series B Financing

NextCure Completes a $93M Series B Financing

Portfolio News

Nov 07, 2018

InCarda Completes $42M Oversubscribed Series B Financing

InCarda Completes $42M Oversubscribed Series B Financing

Portfolio News

Nov 05, 2018

NextCure and Lilly Announce Collaboration to Discover and Develop Novel Immuno-Oncology Medicines

NextCure and Lilly Announce Collaboration to Discover and Develop Novel Immuno-Oncology Medicines

Portfolio News

Nov 02, 2018

U.S. FDA Approves Coherus Biosciences' UDENYCA™

U.S. FDA Approves Coherus Biosciences' UDENYCA™

Sofinnova News

Oct 29, 2018

Sarah Bhagat Named as One of the "Nine VCs Who Matter, but You Never Read About"

Sarah Bhagat Named as One of the "Nine VCs Who Matter, but You Never Read About"

Sofinnova News

Oct 16, 2018

Mike Powell and Jason Pitts Featured in EndPoints Guest Column "The Real Cost of Drug Development"

Mike Powell and Jason Pitts Featured in EndPoints Guest Column "The Real Cost of Drug Development"

Portfolio News

Oct 03, 2018

ObsEva Reports Additional Positive Phase 3 Results IMPLANT 2 Trial Following IVF

ObsEva Reports Additional Positive Phase 3 Results IMPLANT 2 Trial Following IVF

Portfolio News

Sep 28, 2018

ObsEva’s Final Results of Phase 2b EDELWEISS Trial Shows Sustained Efficacy and Safety

ObsEva’s Final Results of Phase 2b EDELWEISS Trial Shows Sustained Efficacy and Safety

Portfolio News

Sep 26, 2018

Entasis Therapeutics Announces Pricing of Initial Public Offering

Entasis Therapeutics Announces Pricing of Initial Public Offering

Portfolio News

Sep 25, 2018

Coherus Biosciences Receives European Commission Approval for Udenyca™

Coherus Biosciences Receives European Commission Approval for Udenyca™

Portfolio News

Sep 24, 2018

Amarin's REDUCE-IT™ Cardiovascular Outcomes Study of Vascepa® Capsules Met Primary Endpoint

Amarin's REDUCE-IT™ Cardiovascular Outcomes Study of Vascepa® Capsules Met Primary Endpoint

Portfolio News

Sep 20, 2018

Y-mAbs Therapeutics Announces Pricing of Initial Public Offering

Y-mAbs Therapeutics Announces Pricing of Initial Public Offering

Portfolio News

Sep 19, 2018

Galera Therapeutics Raises $150M

Galera Therapeutics Raises $150M

Portfolio News

Sep 18, 2018

BioClin Therapeutics Announces New Leadership

BioClin Therapeutics Announces New Leadership

Portfolio News

Sep 13, 2018

Principia Biopharma Announces Pricing of Initial Public Offering

Principia Biopharma Announces Pricing of Initial Public Offering

Portfolio News

Aug 16, 2018

A women’s health startup tried to drum up interest for a much-needed drug. Many men didn’t get it.

A women’s health startup tried to drum up interest for a much-needed drug. Many men didn’t get it.

Portfolio News

Aug 07, 2018

Akouos Raises $50M Series A Financing

Akouos Raises $50M Series A Financing

Portfolio News

May 24, 2018

Iterum Announces the Pricing of Initial Public Offering

Iterum Announces the Pricing of Initial Public Offering

Portfolio News

May 23, 2018

Kiniksa Pharmaceuticals, Ltd. Announces Pricing of Initial Public Offering

Kiniksa Pharmaceuticals, Ltd. Announces Pricing of Initial Public Offering

Portfolio News

May 14, 2018

Entasis Therapeutics Initiates Clinical Studies of the Oral Extended-Spectrum Beta-Lactamase Inhibitor ETX0282

Entasis Therapeutics Initiates Clinical Studies of the Oral Extended-Spectrum Beta-Lactamase Inhibitor ETX0282

Portfolio News

May 07, 2018

BioClin Therapeutics, Inc., Completes $50M Series B Financing with Addition of New Investors

BioClin Therapeutics, Inc., Completes $50M Series B Financing with Addition of New Investors

Portfolio News

Mar 28, 2018

Edge Therapeutics Provides Update following Interim Analysis of Phase 3 NEWTON 2 Study

Edge Therapeutics Provides Update following Interim Analysis of Phase 3 NEWTON 2 Study

Event

Jan 30, 2018

Alan Colowick to Speak at JLABS

Alan Colowick to Speak at JLABS

Portfolio News

Jan 22, 2018

Medeor Therapeutics Awarded $18.8M From the California Institute for Regenerative Medicine

Medeor Therapeutics Awarded $18.8M From the California Institute for Regenerative Medicine

Portfolio News

Jan 04, 2018

Audentes Announces Positive Interim Data from First Dose Cohort of ASPIRO

Audentes Announces Positive Interim Data from First Dose Cohort of ASPIRO

Portfolio News

Jan 03, 2018

Ascendis Announces Completion of Target Enrollment in Phase 3 Trial of TransCon Growth Hormone

Ascendis Announces Completion of Target Enrollment in Phase 3 Trial of TransCon Growth Hormone

Portfolio News

Dec 19, 2017

Spark Therapeutics Announces FDA approval of LUXTURNA™

Spark Therapeutics Announces FDA approval of LUXTURNA™

Portfolio News

Dec 18, 2017

Aerie Pharmaceuticals Announces U.S. FDA Approval of Rhopressa®

Aerie Pharmaceuticals Announces U.S. FDA Approval of Rhopressa®

Portfolio News

Dec 15, 2017

Aclaris Therapeutics Receives FDA Approval for the Treatment of Raised Seborrheic Keratoses

Aclaris Therapeutics Receives FDA Approval for the Treatment of Raised Seborrheic Keratoses

Portfolio News

Dec 13, 2017

Pionyr Immunotherapeutics Completes $62M Series B Financing

Pionyr Immunotherapeutics Completes $62M Series B Financing

Portfolio News

Nov 29, 2017

Y-mAbs Announces Closing of $30M Extension of Private Equity Placement

Y-mAbs Announces Closing of $30M Extension of Private Equity Placement

Portfolio News

Nov 28, 2017

Medeor Therapeutics Raises $57M In Series B Financing

Medeor Therapeutics Raises $57M In Series B Financing

Portfolio News

Nov 14, 2017

Apellis Announces the Pricing of Initial Public Offering

Apellis Announces the Pricing of Initial Public Offering

Portfolio News

Nov 07, 2017

ObsEva Announces Completion of Patient Recruitment for the Treatment of Endometriosis

ObsEva Announces Completion of Patient Recruitment for the Treatment of Endometriosis

Sofinnova News

Oct 24, 2017

Sofinnova Steps Up

Sofinnova Steps Up

Portfolio News

Sep 27, 2017

NuCana PLC Announces Pricing of Initial Public Offering

NuCana PLC Announces Pricing of Initial Public Offering

Portfolio News

Sep 05, 2017

Entasis Announces $31.9M Extension of Series B Financing

Entasis Announces $31.9M Extension of Series B Financing

Portfolio News

Aug 10, 2017

Apellis Pharmaceuticals Announces $60M Series E Financing

Apellis Pharmaceuticals Announces $60M Series E Financing

Portfolio News

Aug 02, 2017

Amplyx Pharmaceuticals Raises $67M in Series C Financing

Amplyx Pharmaceuticals Raises $67M in Series C Financing

Portfolio News

Jun 15, 2017

Art Krieg comes down from the mountain with a $27M round for Checkmate Pharmaceuticals

Art Krieg comes down from the mountain with a $27M round for Checkmate Pharmaceuticals

Event

Jun 09, 2017

Jim Healy to Speak at BIO on Market & Political Pressures

Jim Healy to Speak at BIO on Market & Political Pressures

Event

Jun 07, 2017

Mike Powell to be a Judge at BIO's Start-Up Stadium

Mike Powell to be a Judge at BIO's Start-Up Stadium

Sofinnova News

May 30, 2017

Sofinnova Announces the Addition of Industry Leader Alan Colowick, MD, MPH to its Partnership

Sofinnova Announces the Addition of Industry Leader Alan Colowick, MD, MPH to its Partnership

Event

Apr 11, 2017

Jim Healy to Speak at Cancer Advance Boston

Jim Healy to Speak at Cancer Advance Boston

Portfolio News

Mar 28, 2017

Virtual biotech Antiva sets out on a big R&D quest, armed with a $22M round for an HPV therapy

Virtual biotech Antiva sets out on a big R&D quest, armed with a $22M round for an HPV therapy

Event

Feb 06, 2017

Charlotte Shropshire to Speak at SuperReturn US West

Charlotte Shropshire to Speak at SuperReturn US West

Sofinnova News

Oct 17, 2016

Sofinnova Raises $650M Biotech-focused Venture Fund

Sofinnova Raises $650M Biotech-focused Venture Fund

Sofinnova News

Apr 11, 2016

12 VCs Who Matter, But You Never Read About

12 VCs Who Matter, But You Never Read About

Sofinnova News

Jan 12, 2016

Despite 'choppy' markets, fundamentals strong as health care world heads to JPM

Despite 'choppy' markets, fundamentals strong as health care world heads to JPM